Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000391855

Medchemexpress LLC Urea, N-[1-[(2-amino-4-pyridinyl)methyl]-1H-indol-4-yl]-N'-(5-bromo-2-methoxyphenyl)- | 900573-88-8 | 99.0% | 466.33 | 1 ML
SDP

Supplier:  Medchemexpress LLC HY1626510MM/1ML

Encompass_Preferred

JI-101 is an orally available multi-kinase inhibitor that targets VEGFR2, PDGFRβ, and EphB4. It exhibits potent anti-cancer activity and has been studied for its pharmacokinetics and tissue distribution. The compound is stable in preclinical and human liver microsomes, with relatively higher metabolism in mice compared to dog, human, and rat liver microsomes. Following oral administration, JI-101 is rapidly absorbed, reaching peak concentration within 2 hours, and has an oral bioavailability of 55%. Its primary elimination route is through feces, and it undergoes extensive tissue distribution, with preferential uptake into lung tissue.

  • Orally available
  • Multi-kinase inhibitor, targeting VEGFR2, PDGFRβ, and EphB4
  • Potent anti-cancer activity
  • Stable in preclinical and human liver microsomes
  • Rapidly absorbed after oral administration
  • Extensive tissue distribution, with preferred uptake in lung tissue

Catalog No. 50-003-91855


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.